scispace - formally typeset
S

Silvia Carloni

Researcher at University of Urbino

Publications -  78
Citations -  9150

Silvia Carloni is an academic researcher from University of Urbino. The author has contributed to research in topics: Apoptosis & Neuroprotection. The author has an hindex of 28, co-authored 69 publications receiving 7521 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Protective role of autophagy in neonatal hypoxia–ischemia induced brain injury

TL;DR: Data indicate that autophagy is increased in neuronal cells after neonatal hypoxia-ischemia and suggest that over-activation of autophagic pathways represents a potential protective mechanism in the early stage of the brain injury.
Journal ArticleDOI

Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs

TL;DR: The present study demonstrates for the first time the feasibility of analyzing at the molecular level pure CTCs avoiding lymphocyte contamination using an innovative instrumentation, and a KRAS discordance between C TCs and primary tissue.
Journal ArticleDOI

Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats.

TL;DR: It is demonstrated that melatonin administration before or after HI in immature rats has an excellent and long‐lasting benefit on ischemic outcomes suggesting that the drug could represent a potentially safe approach to perinatal brain damage in humans.